Dexcom has officially launched Stelo, the first over-the-counter continuous glucose biosensor in the U.S. This device provides convenient and accessible glucose monitoring without a prescription. Available exclusively online, Stelo represents a significant advancement in diabetes management, allowing users to monitor their glucose levels with ease. The biosensor is available for a one-time purchase or as a monthly subscription, providing flexibility and affordability. Stelo is designed for people who have type 2 diabetes and are not taking insulin.

I ordered a two-pack on a monthly subscription this morning and will be sharing my review once I’ve had the chance to use it.

For more details, visit Stelo.

Dexcom Stelo

 

JCS/T2D

We are advocates. We learn. We share. We inform.
Bringing clarity to type 2 diabetes, obesity care, health research, and the data behind them.

Content is provided for educational and informational purposes and is not medical advice.